glp-1 and medicare New Bridge Program Today marks the launch of

doi: 10.2337/diabetes.47.5.764

When Microdosing May and May Not Be Considered Situations where microdosing may be considered under medical supervision include: intolerance to the lowest validated initiation dose gradual tapering from a higher maintenance dose structured recalibration when standard titration is not tolerated Situations where microdosing should not replace standard care include: absence of clinician supervision lack of metabolic evaluation or baseline laboratory testing attempts to self-manage dosing outside medical guidance Conclusion GLP-1 microdosing refers to using a lower level of medication exposure within a structured clinical framework

J., Somers, V

We will be diving into the GLP-1 dilemma, exploring how weight loss medications impact eating disorder recovery

Moussa, C., M

Navigate the Silence: Process the psychological shift of living without constant food thoughts